Antiretroviral prophylaxis: a defining moment in HIV control.
作者信息
Karim Salim S Abdool, Karim Quarraisha Abdool
机构信息
Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban 4013, South Africa.
出版信息
Lancet. 2011 Dec 17;378(9809):e23-5. doi: 10.1016/S0140-6736(11)61136-7. Epub 2011 Jul 21.
Abstract
摘要
相似文献
1
Antiretroviral prophylaxis: a defining moment in HIV control.
Lancet. 2011 Dec 17;378(9809):e23-5. doi: 10.1016/S0140-6736(11)61136-7. Epub 2011 Jul 21.
2
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.
Lancet. 2011 Jul 16;378(9787):279-81. doi: 10.1016/S0140-6736(11)60878-7.
3
Preventing HIV in women--still trying to find their VOICE.
N Engl J Med. 2015 Feb 5;372(6):564-6. doi: 10.1056/NEJMe1415750.
4
Study halted: no benefit seen from antiretroviral pill in preventing HIV in women.
JAMA. 2011 May 18;305(19):1952. doi: 10.1001/jama.2011.649.
5
Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial.
AIDS. 2013 Aug 24;27(13):2155-60. doi: 10.1097/QAD.0b013e3283629037.
6
Concentrations of tenofovir and emtricitabine in saliva: implications for preexposure prophylaxis of oral HIV acquisition.
Antimicrob Agents Chemother. 2011 Oct;55(10):4905-7. doi: 10.1128/AAC.00120-11. Epub 2011 Jul 25.
7
FDA paves the way for pre-exposure HIV prophylaxis.
Lancet. 2012 Jul 28;380(9839):325. doi: 10.1016/s0140-6736(12)61235-5.
8
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
N Engl J Med. 2015 Feb 5;372(6):509-18. doi: 10.1056/NEJMoa1402269.
9
[Pre-exposure prophylaxis for HIV transmission? No, unless].
Ned Tijdschr Geneeskd. 2013;157(27):A6359.
10
HIV preexposure prophylaxis: new data and potential use.
Top Antivir Med. 2011 Dec;19(5):181-5.
引用本文的文献
1
Integration of HIV Prevention With Sexual and Reproductive Health Services: Evidence for Contraceptive Options and HIV Outcomes Study Experience of Integrating Oral Pre-exposure HIV Prophylaxis in Family Planning Services in Lusaka, Zambia.
Front Reprod Health. 2021 Jul 13;3:684717. doi: 10.3389/frph.2021.684717. eCollection 2021.
2
Effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in HIV-1 serodiscordant couples in Nigeria.
PLoS One. 2022 May 5;17(5):e0268011. doi: 10.1371/journal.pone.0268011. eCollection 2022.
3
Improving Post-Release Care Engagement for People Living with HIV Involved in the Criminal Justice System: A Systematic Review.
AIDS Behav. 2022 May;26(5):1607-1617. doi: 10.1007/s10461-021-03513-4. Epub 2021 Oct 27.
4
What does PrEP mean for 'safe sex' norms? A qualitative study.
PLoS One. 2021 Aug 5;16(8):e0255731. doi: 10.1371/journal.pone.0255731. eCollection 2021.
5
Reaching underserved South Africans with integrated chronic disease screening and mobile HIV counselling and testing: A retrospective, longitudinal study conducted in Cape Town.
PLoS One. 2021 May 4;16(5):e0249600. doi: 10.1371/journal.pone.0249600. eCollection 2021.
6
Impact of Case Definitions on Efficacy Estimation in Clinical Trials-A Proof-of-Principle Based on Historical Examples.
Antibiotics (Basel). 2020 Jul 4;9(7):379. doi: 10.3390/antibiotics9070379.
7
Long-acting approaches for delivery of antiretroviral drugs for prevention and treatment of HIV: a review of recent research.
Expert Opin Drug Deliv. 2020 Sep;17(9):1227-1238. doi: 10.1080/17425247.2020.1783233. Epub 2020 Jul 6.
8
Brief Report: Randomized Controlled Trial of an Intervention to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options in New York City (All About Me).
J Acquir Immune Defic Syndr. 2020 Jan 1;83(1):31-36. doi: 10.1097/QAI.0000000000002223.
9
Historical and Developmental Changes in Condom Use Among Young Men Who Have Sex with Men Using a Multiple-Cohort, Accelerated Longitudinal Design.
Arch Sex Behav. 2019 May;48(4):1099-1110. doi: 10.1007/s10508-019-1407-8. Epub 2019 Mar 19.
10
The heterogeneous effect of short-term transfers for improving ART adherence among HIV-infected Tanzanian adults.
AIDS Care. 2018;30(Suppl 3):18-26. doi: 10.1080/09540121.2018.1476666. Epub 2018 Jul 8.
本文引用的文献
1
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.
Lancet. 2011 Jul 16;378(9787):279-81. doi: 10.1016/S0140-6736(11)60878-7.
2
Stigma impedes AIDS prevention.
Nature. 2011 Jun 2;474(7349):29-31. doi: 10.1038/474029a.
3
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.
4
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.
Science. 2010 Sep 3;329(5996):1168-74. doi: 10.1126/science.1193748. Epub 2010 Jul 19.
5
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.
N Engl J Med. 2009 Dec 3;361(23):2209-20. doi: 10.1056/NEJMoa0908492. Epub 2009 Oct 20.
6
Male circumcision for prevention of heterosexual acquisition of HIV in men.
Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD003362. doi: 10.1002/14651858.CD003362.pub2.
7
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.
Lancet. 2007 Feb 24;369(9562):657-66. doi: 10.1016/S0140-6736(07)60313-4.
8
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.
Lancet. 2007 Feb 24;369(9562):643-56. doi: 10.1016/S0140-6736(07)60312-2.
9
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.
PLoS Med. 2005 Nov;2(11):e298. doi: 10.1371/journal.pmed.0020298. Epub 2005 Oct 25.
10
Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial.
Lancet. 1995 Aug 26;346(8974):530-6. doi: 10.1016/s0140-6736(95)91380-7.
Zotero 插件